Japan Intellectual Property Rights: AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

Japan, March 25 -- NOVARTIS AG has got intellectual property rights for 'AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS.' Other related details are as follows:

Application Number: JP,2024-193634

Category (FI): A61K31/4427,A61K31/4439,A61K31/4545,A61K31/496,A61K31/5377,A61P19/00,A61P43/00,111,C07D213/82,C07D401/10,C07D401/14,C07D405/14,C07D409/14,C07D491/107

Stage: Grant (IP right document published.)

Filing Date: Nov. 5, 2024

Publication Date: March 11, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.